METHODS
We conducted a systematic review following the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for
reporting results,21 posing the question: “What are
the reported infectious complications of mTOR inhibitors when used to
treat VAs?” We did not register this review protocol.